Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-20-043
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Originally
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Tribal Organizations (Not Federally Recognized)
- State Governments
- Higher Education Inst. (Private)
- 501(c)(3) Nonprofits
- For Profit Organizations
- City/Township Governments
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- County Governments
- Special District Governments
- Small Businesses
- Independent School Districts
- Public or Indian Housing Auth.
- Other
- Non-501(c)(3) Nonprofits
- Points of contact
-
- NIH OER Webmaster fbowebmaster@od.nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health, specifically the National Cancer Institute, is soliciting applications for Cancer Center Support Grants (P30 grants) to fund organizational infrastructure and resources supporting high-quality, interdisciplinary cancer research at designated cancer centers. Applicants must establish an adequate peer-reviewed cancer research base of at least $4.0 million in direct costs annually and demonstrate reasonable depth and breadth of research activities across three major areas: basic laboratory research, clinical research, and prevention/control/population-based research. The grants support scientific leadership salaries, shared research resources, administrative costs, planning and evaluation, and developmental funds for new initiatives. Evaluation criteria include the quality and diversity of established research programs; evidence of high-degree interdisciplinary coordination and cooperation; appropriate organization and facilities; a qualified director with adequate authority; and institutional commitment to the cancer center as a major organizational element. The application deadline is February 23, 2026, and the funding opportunity was initially posted on November 4, 2019.
Awards under this program typically range from approximately $1.2 million to over $25 million in total obligated funding, with standard project periods spanning five years, though extensions to seven years may be permitted. Comprehensive Cancer Centers and Cancer Centers receive support based on their research scope and institutional capabilities, with anticipated annual direct costs varying by center classification. Performance of all research and administrative activities must take place at domestic institutions within the United States, and eligible applicants include higher education institutions (both public and private), nonprofit organizations, government entities, tribal organizations, and other qualified entities with established cancer research infrastructure.
Synopsis
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this FOA are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
Files
| File | Type | Posted |
|---|---|---|
| PKG00259021-instructions.pdf | ||
| PKG00256418-instructions.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity